Compare TXO & LMRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TXO | LMRI |
|---|---|---|
| Founded | 2012 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 691.6M | 753.7M |
| IPO Year | 2022 | N/A |
| Metric | TXO | LMRI |
|---|---|---|
| Price | $12.31 | $10.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $20.50 | ★ $20.75 |
| AVG Volume (30 Days) | 152.8K | ★ 616.7K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | ★ 13.57% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $401,012,000.00 | N/A |
| Revenue This Year | $17.21 | $6.35 |
| Revenue Next Year | N/A | $5.61 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 41.80 | N/A |
| 52 Week Low | $10.12 | $7.23 |
| 52 Week High | $17.90 | $19.45 |
| Indicator | TXO | LMRI |
|---|---|---|
| Relative Strength Index (RSI) | 49.83 | 54.18 |
| Support Level | $12.00 | $9.97 |
| Resistance Level | $12.94 | $16.38 |
| Average True Range (ATR) | 0.39 | 0.56 |
| MACD | 0.04 | 0.21 |
| Stochastic Oscillator | 59.22 | 87.08 |
TXO Partners LP is focused on the acquisition, development, optimization, and exploitation of oil, natural gas, and natural gas liquid reserves in North America. Its operations focus on enhancing the development and operation of producing properties through its concentration on efficiency and optimizing exploitation of current wells.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists' interpretations of those studies.